ES2179847T3 - Metodos biocataliticos para la sintesis e identificacion de compuestos biologicamente activos. - Google Patents

Metodos biocataliticos para la sintesis e identificacion de compuestos biologicamente activos.

Info

Publication number
ES2179847T3
ES2179847T3 ES94925870T ES94925870T ES2179847T3 ES 2179847 T3 ES2179847 T3 ES 2179847T3 ES 94925870 T ES94925870 T ES 94925870T ES 94925870 T ES94925870 T ES 94925870T ES 2179847 T3 ES2179847 T3 ES 2179847T3
Authority
ES
Spain
Prior art keywords
identification
methods
biocatalitical
synthesis
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94925870T
Other languages
English (en)
Inventor
J Wesley Fox
Jonathan S Dordick
Douglas S Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Curia Global Inc
Original Assignee
Albany Molecular Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Molecular Research Inc filed Critical Albany Molecular Research Inc
Application granted granted Critical
Publication of ES2179847T3 publication Critical patent/ES2179847T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/0099—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor comprising robots or similar manipulators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/0068—Means for controlling the apparatus of the process
    • B01J2219/00686—Automatic
    • B01J2219/00691—Automatic using robots

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Robotics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

ESTA INVENCION INCLUYE METODOS PARA LA PRODUCCION DE UNA LIBRERIA DE COMPUESTOS INICIALES MODIFICADOS MEDIANTE EL USO DE REACCIONES BIOCATALITICAS EN UN COMPUESTO INICIAL Y DE IDENTIFICACION DEL COMPUESTO INICIAL MODIFICADO CON LA ACTIVIDAD OPTIMA DESEADA. LA INVENCION INCLUYE COMPUESTOS INICIALES Y COMPUESTOS MODIFICADOS LIBRES EN SOLUCION. EL METODO ES UTIL EN LA PRODUCCION DE COMPUESTOS FARMACEUTICOS MODIFICADOS CON ACTIVIDAD ESPECIFICA DESEADA.
ES94925870T 1993-08-13 1994-08-12 Metodos biocataliticos para la sintesis e identificacion de compuestos biologicamente activos. Expired - Lifetime ES2179847T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10627993A 1993-08-13 1993-08-13

Publications (1)

Publication Number Publication Date
ES2179847T3 true ES2179847T3 (es) 2003-02-01

Family

ID=22310552

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94925870T Expired - Lifetime ES2179847T3 (es) 1993-08-13 1994-08-12 Metodos biocataliticos para la sintesis e identificacion de compuestos biologicamente activos.

Country Status (12)

Country Link
US (1) US20020039723A1 (es)
EP (1) EP0713533B1 (es)
JP (1) JPH09504424A (es)
KR (1) KR960704064A (es)
AT (1) ATE220420T1 (es)
AU (1) AU7564794A (es)
CA (1) CA2169456A1 (es)
DE (1) DE69430954T2 (es)
DK (1) DK0713533T3 (es)
ES (1) ES2179847T3 (es)
PT (1) PT713533E (es)
WO (1) WO1995005475A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2295152A (en) * 1994-11-18 1996-05-22 Pfizer Ltd Preparation of a library of compounds by solid-phase synthesis
US6261813B1 (en) 1995-09-11 2001-07-17 Albany Molecular Research, Inc. Two step enzymatic acylation
CN108486086A (zh) 2003-07-02 2018-09-04 维莱尼姆公司 葡聚糖酶，编码它们的核酸以及制备和使用它们的方法
US20080070291A1 (en) 2004-06-16 2008-03-20 David Lam Compositions and Methods for Enzymatic Decolorization of Chlorophyll
CA2610294C (en) 2005-05-09 2023-10-03 Theranos, Inc. Point-of-care fluidic systems and uses thereof
AU2007356171B8 (en) 2006-08-04 2014-01-16 Bp Corporation North America Inc. Glucanases, nucleic acids encoding them, and methods for making and using them
EP3181228B1 (en) 2007-10-02 2020-07-29 Labrador Diagnostics LLC Modular point-of-care devices and uses thereof
UA111708C2 (uk) 2009-10-16 2016-06-10 Бандж Ойлз, Інк. Спосіб рафінування олії
US8754054B2 (en) 2010-07-09 2014-06-17 Albany Molecular Research, Inc. Antibacterial compounds, methods of making them, and uses thereof
RU2620922C2 (ru) 2011-01-21 2017-05-30 Теранос, Инк. Системы и методы оптимизации использования образца
PL2691720T3 (pl) 2011-03-29 2019-08-30 Kellogg Company Piec z systemem odzyskiwania ciepła
US9632102B2 (en) 2011-09-25 2017-04-25 Theranos, Inc. Systems and methods for multi-purpose analysis
US8840838B2 (en) 2011-09-25 2014-09-23 Theranos, Inc. Centrifuge configurations
US9664702B2 (en) 2011-09-25 2017-05-30 Theranos, Inc. Fluid handling apparatus and configurations
US9268915B2 (en) 2011-09-25 2016-02-23 Theranos, Inc. Systems and methods for diagnosis or treatment
US20140170735A1 (en) 2011-09-25 2014-06-19 Elizabeth A. Holmes Systems and methods for multi-analysis
US8435738B2 (en) 2011-09-25 2013-05-07 Theranos, Inc. Systems and methods for multi-analysis
US9619627B2 (en) 2011-09-25 2017-04-11 Theranos, Inc. Systems and methods for collecting and transmitting assay results
US8475739B2 (en) 2011-09-25 2013-07-02 Theranos, Inc. Systems and methods for fluid handling
US9810704B2 (en) 2013-02-18 2017-11-07 Theranos, Inc. Systems and methods for multi-analysis
US9250229B2 (en) 2011-09-25 2016-02-02 Theranos, Inc. Systems and methods for multi-analysis
US10012664B2 (en) 2011-09-25 2018-07-03 Theranos Ip Company, Llc Systems and methods for fluid and component handling
CN104673850A (zh) * 2015-03-20 2015-06-03 北京农学院 异硫氰酸烯丙酯的固定化酶转化制备方法
CN112725174B (zh) * 2020-12-28 2022-09-06 黑龙江省农业科学院生物技术研究所 一种用于生物印迹酶的制备装置及方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof

Also Published As

Publication number Publication date
AU7564794A (en) 1995-03-14
CA2169456A1 (en) 1995-02-23
PT713533E (pt) 2002-11-29
KR960704064A (ko) 1996-08-31
WO1995005475A1 (en) 1995-02-23
EP0713533A1 (en) 1996-05-29
DK0713533T3 (da) 2002-11-04
US20020039723A1 (en) 2002-04-04
EP0713533B1 (en) 2002-07-10
ATE220420T1 (de) 2002-07-15
JPH09504424A (ja) 1997-05-06
DE69430954D1 (de) 2002-08-14
DE69430954T2 (de) 2003-03-13

Similar Documents

Publication Publication Date Title
ES2179847T3 (es) Metodos biocataliticos para la sintesis e identificacion de compuestos biologicamente activos.
ES2188932T3 (es) Formulacion topica de vitamina d a base de liposomas.
DE3574014D1 (en) Novel biologically active compound having anti-prolyl endopeptidase activity
ES2051797T3 (es) Compuestos de urea y carbamato con actividad antihiperlipidemica y antiaterosclerotica.
ES2162437T3 (es) Preparacion medicinal que contiene un gas noble lipofilo.
ES2029542T3 (es) Procedimiento para la obtencion de polisocianatos que presentan grupos isocianurato y su empleo.
ES2165640T3 (es) Acidos diaminocarboxilicos sustituidos.
ES2195220T3 (es) Acidos sulfonilaminocarboxilicos.
BR0107942A (pt) Polìmeros de proteìna de liberação lenta
ATE203016T1 (de) Cryptophycine
BR9600992A (pt) Compostos piridonassulfonil uréia processo para sua produção e herbicidas contendo os mesmos
DE69801660D1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
BR9305783A (pt) Processo para preparar grânulos dispersiveis em água e grânulos dispersíveis em água
ES2029777T1 (es) Un metodo de preparacion de derivados de acido r-succinico.
ES2041378T3 (es) Procedimiento para la obtencion de catalizadores para la trimerizacion de isocianatos y su empleo.
AR009952A1 (es) Uso de proteinas como agentes contra las enfermedades autoinmunes.
PT734380E (pt) 4-benzoilisoxazois e sua utilizacao como herbicidas
ES2109182B1 (es) Formulacion liquida a base de cepas de los hongos filamentosos trichoderma harzianum y trichoderma viride.
ES553691A0 (es) Procedimiento para la obtencion de un peptido.
ES2183249T3 (es) Extensor de cadena para la sintesis de polimeros heparinizables biocampatibles.
ES2060405T3 (es) Derivado de la melatonina que tiene actividad terapeutica en dermatologia.
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
TW284691B (es)
ES2174494T3 (es) Procedimiento para la obtencion de tiocloroformiatos.
ES2149737T3 (es) Procedimiento para la preparacion de 10,11-dihidro-5h-dibenzo(a,d)ciclohept-5-enos y sus derivados.